Magnesium sulphate versus phenytoin for eclampsia.
Explore this paper's citation graph
Summary
Magnesium sulphate, rather than phenytoin, for women with eclampsia reduces the risk ratio of recurrence of seizures, probably reduces therisk of maternal death, and improves outcome for the baby.
- Type
- review
- Published
- 2010-09-28
- Cited by
- 185
- References
- 0
- OpenAlex
- https://openalex.org/W1881403692
- Semantic Scholar
- https://api.semanticscholar.org/CorpusID:11683109
Keywords
Medicine, Eclampsia, Relative risk, Phenytoin, Confidence interval
References
- Effect of magnesium sulfate on maternal brain blood flow in preeclampsia: A randomized, placebo-controlled study
- Diagnosis, Prevention and Management of Eclampsia
- Phenyltoin versus magnesium sulfate in patients with eclampsia: Preliminary results from a randomized trial
- Interventions for treating pre-eclampsia and its consequences: generic protocol
Cited by
- Use of Evidence-Based Practices in Pregnancy and Childbirth: South East Asia Optimising Reproductive and Child Health in Developing Countries Project
- Health technology assessment in maternal and perinatal medicine : delphi survey of practice, systematic reviews of evidence and meta analyses
- The effect of severity of pre-eclampsia on the basal plate intervillous surface lining components : a confocal laser scanning microscopy study
- Therapeutic uses of magnesium.
- Planned caesarean section versus planned vaginal birth for severe pre-eclampsia.
- Examination of the inflammatory nature of different placental syncytiotrophoblast microparticles (STBM) preparations on human monocytes
- Clinical efficiency in a simulated emergency and relationship to team behaviours: a multisite cross‐sectional study
- Pre-eclampsia, eclampsia, and hypertension.
- More to teamwork than knowledge, skill and attitude
- Clinical practice guidelines for approaching pregnancy-associated hypertensive complications
- Impact of Increasing Capacity for Generating and Using Research on Maternal and Perinatal Health Practices in South East Asia (SEA-ORCHID Project)
- Hypertensive disorders of pregnancy.
- Safety of anticonvulsant agents in pregnancy
- Diuretics vs. placebo for postpartum blood pressure control in preeclampsia (DIUPRE): a randomized clinical trial
- Blood loss at cesarean delivery in women on magnesium sulfate for preeclampsia
- Addressing potential role of magnesium dyshomeostasis to improve treatment efficacy for epilepsy: A reexamination of the literature
- Pharmacotherapy for Status Epilepticus
- Reducing maternal and neonatal deaths in ruralMalawi: evaluating the impact of a community-basedwomen’s group intervention
- Blood pressure assessment and first-line pharmacological agents in women with eclampsia.
- Magnesium Sulfate for the Treatment of Eclampsia: A Brief Review
Related papers
- Carbamazepine increases phenytoin serum concentration and reduces phenytoin clearance
- Folate supplements and phenytoin‐sa]licylate interaction
- Human brain phenytoin: correlation with unbound and total serum concentrations.
- The reversibility of phenytoin-induced IgA deficiency
- Calculated free phenytoin and albumin adjusted total phenytoin versus measured free phenytoin
- INTERACTION BETWEEN PHENYTOIN AND VALPROATE
- The clinical value of free phenytoin levels
- The effect of multiple anticonvulsant therapy on the expression of phenytoin-induced gingival overgrowth.
- Correlation of serum total and free phenytoin levels with drug intake and seizure control